Renal Cell Carcinoma (RCC), the most prevalent kidney cancer, has seen rising incidence but declining mortality due to new treatments like VEGFR-targeting TKIs. Yet, curative options remain elusive. Combined therapy involving VEGFR Tyrosine Kinase Inhibitors (TKIs) and immune checkpoint inhibitors (CPIs) has gained importance for advanced RCC (1).
423 Reached
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Black Lesion in Old Female
1963 Reached5 Comments11 Likes
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1004 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
2601 Reached1 Comments4 Likes
Management of Metastatic Prostate Cancer
1035 Reached5 Comments2 Likes